InvestorsHub Logo

doogdilinger

07/20/17 9:32 AM

#28304 RE: illmatix #28303

Nice find thnx illmatix>>> 12 institutional investors are raising stakes in IntelliPharmaCeutics International Inc. (IPCI)
July 20, 2017

IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) enjoyed a 80.39% run-up in share price since hitting record low of $1.53. The stock managed -2.13% fall and now stands at $2.76 as of Jul. 19, 2017. At recent session, the prices were hovering between $2.73 and $2.87. This company shares are 132.97% off its target price of $6.43 and the current market capitalization stands at $83.96M. The recent change has given its price a 26.56% lead over SMA 50 and -17.61% deficit over its 52-week high. The stock witnessed 26.12% gains, 28.28% gains and 9.06% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found IPCI’s volatility during a week at 5.71% and during a month it has been found around 6.36%.

IntelliPharmaCeutics International Inc. 13F Filings

At the end of recent reporting period, 12 institutional holders increased their position in IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) by some 542,842 shares, 11 decreased positions by 128,024 and 5 held positions by 448,957. That puts total institutional holdings at 1,119,823 shares, according to SEC filings. The stock grabbed 3 new institutional investments totaling 40,688 shares while 6 institutional investors sold out their entire positions totaling 76,778 shares.

IntelliPharmaCeutics International Inc. (IPCI) Analyst Guide

Several analysts have released their opinion on IntelliPharmaCeutics International Inc. (NASDAQ:IPCI), with 2 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.43 average brokerage recommendation.